Drug use evaluation of liraglutide in type 2 diabetes mellitus patients
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: HUANG, Yun-Ting (Taipei, China Taiwan)
- Co-author(s): Tsai, Tzu-Cheng (, Taipei, China Taiwan)
Chen, Wei-Li (, Taipei, China Taiwan)
Deng, Shin-Tarng (, Taipei, China Taiwan)
Diabetes mellitus (DM) and its complications have been major cause of death in theworld. A new glucagon-like peptide 1 (GLP-1) analog, liraglutide, was availablein medical hospital in April 2013. Liraglutide and exenatide are both GLP-1analogs, however, patients often withdraw exenatide due to adverse effects.
To investigate.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.